PT-141 Peptide Purity Specs Manufacturing Sourcing Guide
Executive Summary
PT-141 peptide is a specialized research compound positioned for investigational applications in melanocortin receptor studies. This sourcing guide focuses on purity specifications, typically requiring ≥98% verified by HPLC and mass spectrometry to ensure reliable experimental outcomes. Manufacturing follows cGMP standards in ISO-certified facilities, with strict endotoxin and heavy metal controls. Applications center on receptor binding and neurological pathway research, not human use. Quality advantages include batch-specific COAs, third-party lab verification, and lyophilized powder stability. Buyer pain points include inconsistent purity from unverified suppliers, mislabeled peptides, and lack of transparent documentation. This guide addresses these by outlining critical purity thresholds, recommended manufacturing protocols, and sourcing red flags. Prioritize vendors offering full analytical data and chain-of-custody records to maintain research integrity and reproducibility.
Target Keyword: pt 141 peptide
PT-141 peptide is a synthetic cyclic heptapeptide positioned exclusively for investigational research applications, specifically targeting melanocortin receptors (MC3R and MC4R) in controlled laboratory environments. For B2B buyers in the cosmetic raw material and laboratory supply sectors, this compound represents a specialized tool for receptor binding assays and neurological pathway studies. Its commercial value lies in its high specificity for melanocortin pathways, enabling reproducible data generation in preclinical research, with no approved applications for human consumption or therapeutic use.
Core Molecular Specs & Product Technical Index
PT-141 peptide, also known as bremelanotide acetate, is characterized by a molecular weight of approximately 1025.2 g/mol and a molecular formula of C50H68N14O10. The peptide sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, featuring a cyclic structure that enhances receptor binding affinity. Production purity grade must meet ≥98% purity verified by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to ensure batch-to-batch consistency. Solubility is optimized in sterile water or phosphate-buffered saline (PBS) at pH 7.4, with recommended storage at -20°C in lyophilized form to maintain stability for up to 24 months. National industry testing standards follow USP <797> for pharmaceutical compounding and ICH Q2(R1) for analytical method validation.
- Purity threshold: ≥98% by HPLC with single impurity ≤0.5%
- Peptide content: 70-90% net peptide weight, corrected for counterion and moisture
- Endotoxin level: ≤1.0 EU/mg for research-grade material
- Heavy metals: ≤10 ppm total, with lead ≤1 ppm and arsenic ≤1 ppm
- Solubility: ≥10 mg/mL in water, clear solution without visible particulates
According to a 2023 market analysis by Grand View Research, the global peptide synthesis market is projected to reach USD 68.5 billion by 2030, with research-grade peptides like PT-141 accounting for 12% of demand due to increasing focus on melanocortin receptor studies in neurological and metabolic research.
Manufacturing Flow & Strict Quality Control System
The manufacturing process for PT-141 peptide begins with raw material screening of Fmoc-protected amino acids, each batch tested for chiral purity and absence of racemization. Solid-phase peptide synthesis (SPPS) is employed using a Rink amide resin, followed by cyclization in solution to form the critical disulfide bridge. Multi-stage purification involves preparative HPLC with a C18 column, achieving baseline separation of target peptide from truncated sequences. Third-party testing certification includes batch-specific Certificates of Analysis (COAs) with HPLC chromatograms, MS spectra, and amino acid analysis reports. Long-term stability tests are conducted under accelerated conditions (40°C/75% RH for 6 months) and real-time storage (-20°C for 24 months) to confirm degradation profiles.
Main Certification Standards We Support
- cGMP compliance with ISO 9001:2015 quality management system
- ISO 13485:2016 for medical device raw materials (research use only)
- USP <787> for peptide purity and impurity profiling
- ICH Q3D for elemental impurities control
- FDA 21 CFR Part 11 for electronic data integrity and audit trails
Main Commercial Application Scenarios
PT-141 peptide is utilized in three primary B2B commercial channels: cosmetic ingredient blending, laboratory research supply, and compound raw material wholesale. In cosmetic blending, it serves as a research tool for formulators developing topical delivery systems targeting melanocortin receptors in skin models, though no finished cosmetic products are approved for human use. For laboratory research, it is supplied as a lyophilized powder in 5 mg, 10 mg, and 50 mg vials for receptor binding assays, cAMP accumulation studies, and in vitro neuronal activation experiments. In compound raw material wholesale, bulk quantities (100 mg to 10 grams) are distributed to contract research organizations (CROs) and academic institutions for preclinical studies.
- Cosmetic blending: Used in formulation stability tests at 0.1-1.0% concentration in cream bases, with pH 5.5-6.5 for optimal peptide integrity
- Laboratory research: Applied in MC4R agonist screening assays with EC50 values typically 0.1-1.0 nM, using HEK293 cell lines
- Compound raw material wholesale: Bulk orders include custom packaging with desiccant and argon flush, ensuring ≤0.5% moisture content
Comparison: pt-141 peptide VS Ordinary Low-Grade Peptide Raw Materials
| Item | Our High-Purity Product | Common Alternatives | Advantage |
| Purity (HPLC) | ≥98% with single impurity ≤0.5% | 90-95% with multiple impurities >1% | Higher specificity reduces off-target effects in assays |
| Endotoxin Level | ≤1.0 EU/mg | 5-20 EU/mg | Lower risk of cell activation in in vitro studies |
| Batch Documentation | Full COA with HPLC, MS, AA analysis | Basic COA or no third-party data | Traceable quality for reproducible research |
| Stability at -20°C | ≥24 months with ≤2% degradation | 6-12 months with >5% degradation | Longer shelf life reduces inventory waste |
| Heavy Metals | ≤10 ppm total | 50-100 ppm total | Complies with ICH Q3D for research safety |
Standard Buyer Selection Guide For Bulk Purchase
Common purchasing pitfalls include inconsistent purity from unverified suppliers, mislabeled peptides with incorrect sequences, and lack of transparent documentation such as chain-of-custody records. Core screening criteria require verification of HPLC purity ≥98% with a UV detector at 214 nm and mass spectrometry confirmation of molecular weight within ±0.5 Da. Supplier qualification verification methods include requesting batch-specific COAs, checking ISO certification validity via online registries, and requesting a reference standard for in-house testing. Red flags include suppliers unable to provide raw data files, offering prices below $50 per 10 mg for research-grade material, or lacking a physical address and GMP facility documentation.
Key Inspection Checklist Before Cooperation
- Request three consecutive batch COAs with HPLC chromatograms and MS spectra
- Verify supplier ISO 9001:2015 certification through an accredited body (e.g., SGS, BSI)
- Confirm endotoxin testing method (LAL or rFC) and acceptable limits
- Check storage and shipping conditions: lyophilized powder at -20°C with dry ice for international orders
- Review chain-of-custody documentation from raw material to final product
Core Competitive Advantages Of Our pt-141 peptide
Our PT-141 peptide offers distinct advantages in purity, stability, cost performance, and after-sales technical support. Purity is consistently ≥98% with single impurity levels below 0.5%, verified by HPLC and MS for every batch, ensuring minimal interference in receptor binding studies. Stability is enhanced through lyophilization with a trehalose excipient, maintaining >95% potency after 24 months at -20°C, compared to industry average of 12 months. Cost performance is optimized through direct manufacturing without intermediaries, offering bulk pricing at $35-45 per 10 mg for orders over 500 mg, with volume discounts up to 20% for 5-gram orders. After-sales technical support includes free consultation on reconstitution protocols, solubility optimization, and assay compatibility, with a dedicated account manager for each B2B client.
Frequently Asked Questions
Q: What is the minimum purity requirement for PT-141 peptide in research applications, and how is it verified?
A: The minimum purity requirement for PT-141 peptide in investigational research is ≥98% as determined by HPLC with UV detection at 214 nm. Verification involves running a gradient elution method (5-60% acetonitrile in 0.1% TFA over 30 minutes) on a C18 column, with purity calculated by area normalization. Mass spectrometry confirmation is mandatory to verify the molecular weight within ±0.5 Da of the theoretical value (1025.2 g/mol). Batch-specific COAs must include the HPLC chromatogram, MS spectrum, and amino acid analysis report for full traceability.
Q: How should PT-141 peptide be stored to maintain stability for long-term research use?
A: PT-141 peptide should be stored as a lyophilized powder at -20°C in a desiccated environment, protected from light and moisture. Under these conditions, stability is maintained for up to 24 months with ≤2% degradation. For reconstituted solutions, use sterile water or PBS at pH 7.4, and store at 4°C for up to 7 days or at -20°C for up to 30 days. Avoid repeated freeze-thaw cycles by aliquoting into single-use vials. Always verify peptide content via UV absorbance at 280 nm before use, as counterion and moisture content can vary between batches.
Q: What documentation should a reputable supplier provide for bulk PT-141 peptide orders?
A: A reputable supplier should provide a comprehensive Certificate of Analysis (COA) for each batch, including HPLC purity percentage with chromatogram, mass spectrometry confirmation with spectrum, amino acid analysis showing composition within ±10% of theoretical, endotoxin level (≤1.0 EU/mg), heavy metals report (≤10 ppm total), and moisture content (≤5%). Additionally, chain-of-custody records from raw material sourcing through synthesis and purification, along with ISO 9001:2015 certification, are essential for maintaining research integrity and reproducibility. Third-party testing from an accredited laboratory (e.g., Eurofins, SGS) adds an extra layer of verification.
